Corpus Intelligence IC Memo — MEADOWVIEW REGIONAL MEDICAL CENTER 2026-04-26 14:13 UTC
IC Memo — MEADOWVIEW REGIONAL MEDICAL CENTER
Investment Committee Memorandum | KY | 100 beds | Grade D | EBITDA uplift $5.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEADOWVIEW REGIONAL MEDICAL CENTER

CCN 180019 | MASON, KY | 100 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MEADOWVIEW REGIONAL MEDICAL CENTER is a 100-bed suburban community hospital in MASON, KY with $75.2M in net patient revenue and a 3.2% operating margin. The hospital serves a payer mix of 24.6% Medicare, 0.6% Medicaid, and 74.8% commercial.

Thesis: Turnaround. Our ML models identify $5.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.2% to 10.5% (+736bps).

Net Revenue HCRIS$75.2M
Current EBITDA COMPUTED$2.4M
Operating Margin COMPUTED3.2%
Occupancy HCRIS16.1%
Revenue / Bed COMPUTED$752K
Net-to-Gross HCRIS18.6%
Distress Probability ML54.4%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
44
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 3.2% places it above the state median. Among 44 size-comparable peers (50-200 beds), the median margin is 0.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-200), prioritizing same-state peers. 44 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEADOWVIEW REGIONAL MEDICAL CE (Target)KY100$75.2M3.2%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
MERCY HEALTH LOURDES HOSPITAL KY178$288.1M7.7%
BAPTIST HEALTH CORBINKY197$285.4M1.4%
LAKE CUMBERLAND REGIONAL HOSPKY179$278.7M5.6%
BAPTIST HEALTH MADISONVILLEKY154$220.0M-5.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
EPHRAIM MCDOWELL REG MED CTRKY157$207.7M-13.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.6M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$915K+122bp9mo
Clean Claim Rate88.0%96.0%$48K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.6M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$915K
Clean Claim Rate
$48K
Total EBITDA Uplift$5.5M
Current EBITDA$2.4M
+ RCM Uplift+$5.5M
Pro Forma EBITDA$7.9M
Current Margin3.2%
Pro Forma Margin10.5%
WC Released (1x)$2.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.6M$71.0M19.46x81.1%
Base (11x exit)10.0x11.0x$3.6M$79.3M21.73x85.1%
Bull Case9.0x11.0x$3.3M$98.7M30.07x97.5%
Bull (12x exit)9.0x12.0x$3.3M$108.7M33.10x101.4%
Bear Case11.0x10.0x$4.0M$42.1M10.50x60.0%
Bear (11x exit)11.0x11.0x$4.0M$47.7M11.87x64.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 16.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 44 hospitals with 50-200 beds
  • Same-state prioritization (n=45)
  • Comp margins: P25=-9.8% / P50=0.6% / P75=11.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.